Company: SUPN
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001356576-25-000055
Chunk: 134

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 8
Chunk 134
---
 Significant segment expenses:Cost of goods sold16,827 17,916 32,590 34,225 Selling44,398 39,094 87,012 78,108 Marketing20,732 19,710 41,396 40,263 General and administrative28,421 27,100 55,087 54,049 Research and development expensesExternal development program expenses:ONAPGO789 309 1,261 1,093 SPN-8202,199 6,604 6,962 13,342 SPN-8173,446 1,898 7,017 3,020 Qelbree2,224 3,880 6,637 5,931 Early-stage programs and other expenses3,479 4,158 6,692 8,173 Total external development program expenses12,137 16,849 28,569 31,559 Internal employee-related expenses9,978 9,334 20,473 19,554 Total research and development expenses22,115 26,183 49,042 51,113 Other segment items(a)10,461 18,406 39,478 34,171 Net earnings$22,499 $19,916 $10,672 $20,040 (a) Other segment items include amortization of intangible assets, intangible asset impairment charges, contingent consideration gain or loss, net interest and other income, interest expense, and income tax expense, whose amounts are disclosed in the condensed consolidated statement of earnings.

19

14.    Composition of Other Balance Sheet Items

The following details the composition of other balance sheet items (dollars in thousands for amounts in tables):

Inventories, Net June 30,2025December 31,2024(unaudited)Raw materials$8,419 $11,127 Work in process15,650 26,725 Finished goods19,954 16,441 Total$44,023 $54,293 

Property and Equipment, Net June 30,2025December 31,2024(unaudited)Lab equipment and furniture$13,959 $13,370 Leasehold improvements14,023 14,023 Software883 883 Computer equipment1,183 1,112 Subtotal30,048 29,388 Less